Showcases
Pricing
Log In
Free Trial
US-listed companies
TRINITY BIOTECH PLC
TRINITY BIOTECH PLC
TRIB
Market cap
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Revenue
99
97
90
102
93
75
Cost of sales
57
56
52
53
55
53
Gross profit
42
41
38
49
38
22
Other operating income
0
0
0
2
5
0
Research and development expenses
6
5
5
5
4
4
Selling, general and administrative expenses
32
29
28
26
25
29
Selling, general and administrative expenses - closure costs
-
-
-
2
-
-
Selling, general and administrative expenses - recognition of contingent asset
-
-
-
1
-
-
Impairment charges
42
27
24
18
7
6
Operating (loss)/profit
-38
-20
-24
0
7
-17
Financial income
3
2
1
0
1
0
Financial expenses
5
5
7
7
7
25
Net financing expense
-2
-3
-6
-7
-6
-24
(Loss)/profit before tax
-40
-23
-30
-7
1
-41
Total income tax credit
-1
-1
-1
-1
-0
-0
(Loss)/profit for the year on continuing operations
-39
-23
-29
-6
1
-41
Loss for the year on discontinued operations
-2
1
0
0
-
-
American depositary share
-
-
-
-
-
41
Class A Ordinary shares
-
-
-
-
-
41
(Loss)/profit for the year (all attributable to owners of the parent)
-40
-22
-29
-6
1
-41
American depositary share
-1.79
-1.08
-1.39
-0.29
0.04
-1.22
Class A Ordinary shares
-0.45
-0.27
-0.35
-0.07
0.01
-0.3
American depositary share
-1.79
-1.08
-1.39
-0.29
0.04
-1.22
Class A Ordinary shares
-0.45
-0.27
-0.35
-0.07
0.01
-0.3
American depositary share
-1.86
-1.06
-1.38
-0.31
0.04
-1.22
Class A Ordinary shares
-0.47
-0.26
-0.35
-0.08
0.01
-0.3
American depositary share
-1.86
-1.06
-1.38
-0.31
0.04
-1.22
Class A Ordinary shares
-0.47
-0.26
-0.35
-0.08
0.01
-0.3